This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the impact of GLP-1 agonists on patient eligibility for bariatric surgeries and the need for new surgical systems

Ticker(s): ISRG, NVO, LLY, MDT

Who's the expert?

Institution: Cleveland Clinic

  • General surgeon specializing in bariatric surgery at the Clevlend Clinic
  • Conducts 12-15 bariatric surgeries monthly
  • Author or co-author in over 300 peer-reviewed publications, over 30 book chapters and more than 20 educational videos

Interview Questions
Q1.

Please describe your background and practice setting

Added By: ben_admin
Q2.

How many bariatric surgeries do you perform monthly?

Added By: ben_admin
Q3.

Describe the impact GLP1 agonists, like tirzepatide and semaglutide, have had on your patient volumes

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.